Santa Clara, CAAt least 70 complaints have been filed against Ozempic, Wegovy, Saxenda, and Trulicity claiming that GLP-1 receptor agonists triggered irreversible eye damage called non-arteritic anterior ischemic optic neuropathy (NAION). Legal... Read more »
In Incyte Corp. v. Sun Pharmaceutical Industries, the US Court of Appeals for the Federal Circuit dismissed an inter partes review (IPR) petitioner’s appeal of its Patent Trial and Appeal Board (PTAB)... Read more »
Washington, DC “‘You’ve got the shrinks!’ cried Mr Twit.” Roald Dahl’s “The Twits” tells the story of a deliciously dreadful old couple who torment each other (and their pet monkeys) with malicious pranks,... Read more »
Philadelphia, PAIn February, the rapidly growing number of Ozempic side effect lawsuits was consolidated for pre-trial proceedings in the Eastern District of Pennsylvania. Multidistrict Litigation (MDL) 3094 was stalled at first, but... Read more »
Ozempic lawsuits allege Novo Nordisk failed to warn consumers that its diabetes and weight loss drug carries dangerous side effects, including severe gastroparesis (known as stomach paralysis), gastroenteritis, gallbladder disease and other... Read more »
On January 1, 2024, most California employers are required to provide up to five days of unpaid leave to an employee who experiences a reproductive loss event. Senate Bill 848 defines a... Read more »
Senate Bill (SB) 848, scheduled to go into effect on January 1, 2024, requires employers with 5 or more employees to provide employees who have worked for at least 30 days with... Read more »
Happy Thursday TCPA World! R.E.A.C.H. is literally fighting to keep the lead generation industry alive and cases like this make it really hard to show the FCC that businesses, especially publicly traded ones,... Read more »